Table 1.
Patient characteristics | Data |
Age1 (yr) | 76 (18-93) |
Sex | |
Female | 71 (57%) |
Male | 53 (43%) |
Nursing home residency | 19 (15%) |
Charlson’s comorbidity score | 4 (0-10) |
GI procedures including PEG and surgery | 13 (10%) |
Previous medication: | |
Antibiotic therapy within 6 wk prior to onset CDAD | 101 (81%) |
Acid-suppressive therapy | 66 (53%) |
Immunosuppressive therapy | 25 (20%) |
Opioid use | 57 (46%) |
Laxative use | 30 (24%) |
Clinical features of CDAD | |
Hospital-acquired CDAD | 101 (81%) |
Interval onset of diarrhoea to CDAD therapy ≥ 7 d | 45 (37%) |
Body temperature ≥ 38°C | 56 (45%) |
Severe CDAD | 27 (22%) |
Laboratory at diagnosis: | |
White blood cell count (G/L) | 14.1 (4.6-81.3) |
CRP (mg/L) | 118 (2-413) |
Creatinine (mg/L) | 11.5 (3.1-110.5) |
Sodium (mmol/L) | 136 (114-145) |
Potassium (mmol/L) | 3.52 (2.43-5.07) |
Continuation of initial antibiotic therapy despite CDAD | 71 (57%) |
Antibiotic therapy for CDAD | 113 (91%) |
Length of hospital stay > 14 d | 70 (56%) |
30-d mortality | 13 (10%) |
Data are given as median (range) or number (percentage).